Indexed keywords
CALCINEURIN;
RITUXIMAB;
SOLUBLE UROKINASE TYPE PLASMINOGEN ACTIVATOR RECEPTOR;
UNCLASSIFIED DRUG;
UROKINASE RECEPTOR;
AFRICAN AMERICAN;
ANGIOGENESIS;
CELL ADHESION;
CELL MIGRATION;
CELL PROLIFERATION;
CRITICAL ILLNESS;
FIBROBLAST;
FOCAL GLOMERULOSCLEROSIS;
GLOMERULUS FILTRATION RATE;
HEART INFARCTION;
HIGH RISK PATIENT;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS;
IMMUNOCOMPETENT CELL;
KERATINOCYTE;
KIDNEY TRANSPLANTATION;
LYMPHOCYTE;
MALARIA;
MONOCYTE;
NEUTROPHIL;
OUTCOME ASSESSMENT;
PLASMAPHERESIS;
PODOCYTE;
PRIORITY JOURNAL;
PROTEINURIA;
REVIEW;
SMOOTH MUSCLE FIBER;
TUBERCULOSIS;
FEMALE;
GLOMERULOSCLEROSIS, FOCAL SEGMENTAL;
HUMANS;
MALE;
RECEPTORS, UROKINASE PLASMINOGEN ACTIVATOR;
1
78149297155
Circulating permeability factors in idiopathic nephrotic syndrome and focal segmental glomerulosclerosis
McCarthy, E. T., Sharma, M. & Savin, V. J. Circulating permeability factors in idiopathic nephrotic syndrome and focal segmental glomerulosclerosis. Clin. J. Am. Soc. Nephrol. 5, 2115-2121 (2010).
(2010)
Clin. J. Am. Soc. Nephrol. , vol.5
, pp. 2115-2121
McCarthy, E.T.1
Sharma, M.2
Savin, V.J.3
2
79961132981
Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis
Wei, C. et al. Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis. Nat. Med. 17, 952-960 (2011).
(2011)
Nat. Med. , vol.17
, pp. 952-960
Wei, C.1
3
38049032013
Modification of kidney barrier function by the urokinase receptor
Wei, C. et al. Modification of kidney barrier function by the urokinase receptor. Nat. Med. 14, 55-63 (2008).
(2008)
Nat. Med. , vol.14
, pp. 55-63
Wei, C.1
4
84870546490
Circulating suPAR in two cohorts of primary FSGS
Wei, C. et al. Circulating suPAR in two cohorts of primary FSGS. J. Am. Soc. Nephrol. 23, 2051-2059 (2012).
(2012)
J. Am. Soc. Nephrol. , vol.23
, pp. 2051-2059
Wei, C.1
5
4344614173
88-274 fragment of the urokinase receptor inhibits monocyte chemotaxis and integrin-dependent cell adhesion
88-274 fragment of the urokinase receptor inhibits monocyte chemotaxis and integrin-dependent cell adhesion. J. Cell Sci. 117, 2909-2916 (2004).
(2004)
J. Cell Sci. , vol.117
, pp. 2909-2916
Furlan, F.1
6
73349125115
SuPAR: The molecular crystal ball
Thuno, M., Macho, B. & Eugen-Olsen, J. suPAR: the molecular crystal ball. Dis. Markers 27, 157-172 (2009).
(2009)
Dis. Markers , vol.27
, pp. 157-172
Thuno, M.1
MacHo, B.2
Eugen-Olsen, J.3
7
84866730075
Usefulness of suPAR as a biological marker in patients with systemic inflammation or infection: A systematic review
Backes, Y. et al. Usefulness of suPAR as a biological marker in patients with systemic inflammation or infection: a systematic review. Intensive Care Med. 38, 1418-1428 (2012).
(2012)
Intensive Care Med. , vol.38
, pp. 1418-1428
Backes, Y.1
8
84860383287
Serum-soluble urokinase receptor concentration in primary FSGS
Maas, R. J., Wetzels, J. F. & Deegens, J. K. Serum-soluble urokinase receptor concentration in primary FSGS. Kidney Int. 81, 1043-1044 (2012).
(2012)
Kidney Int. , vol.81
, pp. 1043-1044
Maas, R.J.1
Wetzels, J.F.2
Deegens, J.K.3
9
84884211336
The calcineurin-NFAT pathway allows for urokinase receptor-mediated beta3 integrin signaling to cause podocyte injury
Zhang, B. et al. The calcineurin-NFAT pathway allows for urokinase receptor-mediated beta3 integrin signaling to cause podocyte injury. J. Mol. Med. (Berl.) 90, 1407-1420 (2012).
(2012)
J. Mol. Med. (Berl.) , vol.90
, pp. 1407-1420
Zhang, B.1
10
79957836560
Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis
Fornoni, A. et al. Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis. Sci. Transl. Med. 3, 85ra46 (2011).
(2011)
Sci. Transl. Med. , vol.3
Fornoni, A.1
